Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
about
Combined effect of lung function level and decline increases morbidity and mortality risksCOPD and stroke: are systemic inflammation and oxidative stress the missing links?Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysisClosing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary diseaseEffect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare recordsLung Function, Percent Emphysema, and QT Duration: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung StudyIs periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.Methods of data collection and definitions of cardiac outcomes in the Rotterdam StudyEarly influences on cardiovascular and renal developmentDysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence.The Generation R Study: design and cohort update 2012.Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysisThe Rotterdam Study: 2012 objectives and design update.Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial.Mortality among subjects with chronic obstructive pulmonary disease or asthma at two respiratory disease clinics in OntarioImpact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke--a retrospective analysis.A Comparative Study of Physiological Monitoring with a Wearable Opto-Electronic Patch Sensor (OEPS) for Motion Reduction.Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study).Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique.COPD disease severity and the risk of venous thromboembolic events: a matched case-control study.UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD.Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol.Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period.Sex-specific differences in the presenting location of a first venous thromboembolism.Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular riskChronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.Chronic Obstructive Pulmonary Disease and the Risk of Stroke.Hospital-related first venous thromboembolism and risk of recurrence.Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study.Cardiac autonomic function in patients with acute exacerbation of chronic obstructive pulmonary disease with and without ventricular tachycardia.Phosphodiesterase type 4 blockade prevents platelet-mediated neutrophil recruitment at the site of vascular injuryChronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular function.Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study.Impact of sleep-disordered breathing on coagulation: the role of COPD should be clarified.
P2860
Q23919385-97673C67-9502-40D6-8A2C-70E0AA6B68E8Q26746530-5006A5E0-F8CF-4B18-8E70-ABA647FD32EDQ26781406-813E9D94-439B-450F-8504-7E64A014E63AQ28646419-990203A8-F1A3-4FA9-AAC8-E9F6DE82AAF9Q28660388-64282C9B-EACD-4F0C-A07B-32EB621D29A5Q29248734-C11AFF60-1D9D-4852-B7EC-D770FD2065F0Q33649907-AFCE3DF8-DAFD-45A3-96E8-58131E4126F2Q33689926-04E492E7-C98F-4E0E-A2D1-F06124C88A50Q34184048-7DD8E99C-A469-47BA-9E2B-EAED8C5796F7Q34238800-C9CD7A51-7562-45FD-80F4-C07A1B4C6940Q34360591-80362D13-512D-4B32-8E42-0C7AE3A36870Q34644331-095EABD8-19CA-4BEA-B93A-95DB9B8CD2F9Q34998154-CD1911C4-69E6-4AA0-A482-FEBFB00C5463Q35201574-A874B5ED-8390-4184-A7D0-07017BBB4FBFQ35623976-6B0125D1-61D9-437A-B72C-8F7946E08538Q35686996-FFA06632-73B2-4B51-8BC3-C9F1129513B2Q35703788-B69FD312-59E5-49FA-AA02-035FB893A4A4Q35767140-A75F9ECE-4E49-40F9-BB1C-DCD6099BB51EQ35824579-1BE279B2-D7E5-4524-A362-92FD29A11AEDQ36308003-7B9FF68E-1546-405D-9A24-3910FD3109B2Q36539136-BBB2654D-6B97-467E-9853-33945830FFBFQ36579154-189AE8AD-D23A-43C0-BAC6-428059DBEADAQ36861849-C9179075-4E0F-4A83-B43B-31F1AB8EA0D5Q37409751-1A308671-ECE4-4386-B1A9-9CF78E663E08Q37516810-4BC243DB-9083-48D8-890E-DC71B9AF2428Q37987211-01A4A0C2-A39D-41E0-8360-20E259E1B9F7Q38688695-401EAB95-5DA9-4B52-B468-7A7D154A6C1FQ38821459-12A002B2-FF61-453B-B851-6B39650FDFE0Q38833618-267726B0-5BC3-4508-91AF-0009D347DC28Q38944856-99CAAE1B-AE61-46AB-86ED-1B003FEC3A2EQ39268464-D0AF5904-FBEF-4AFF-928A-63EF02ED49C0Q40596897-DA353F6F-1978-4CDC-BE55-04D5E22AED93Q40785891-84E8D6CD-6126-49BC-8CAE-789A29EE5435Q40854299-D9C21CFB-7119-451D-896F-6ADD67B76B10Q41297968-DD8F2BC6-6685-428D-BE03-565D50D6FC0BQ41498412-550AF916-7936-48AF-8E58-0648D901F924Q42761498-F209BB0E-C54B-4845-B3C5-B1E33EF385DBQ46204206-E46EC5EE-50DB-48FE-9DC1-0A5E0FDFF1A8Q48014456-1FF28B3E-D1CF-46C9-9897-03B881633241Q48296818-DA129E61-72B9-4335-864B-7876F28FC8D2
P2860
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
description
im Februar 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 27 February 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2010
@uk
name
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
@en
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
@nl
type
label
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
@en
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
@nl
prefLabel
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
@en
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
@nl
P1476
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases
@en
P2093
Christoph R Meier
Ulrich Bothner
P2888
P304
P356
10.1007/S10654-010-9435-7
P577
2010-02-27T00:00:00Z